March 10, 2023
Bulletin interne de l'Institut Pasteur
Two effective new antiviral drugs for SARS-CoV-2
The availability of SARS-CoV-2 vaccines and the first antiviral drugs at the end of 2020 led to a reduction in the number of infections and the severity of the disease. But the emergence of new variants and the waning effectiveness of vaccines over time mean that SARS-CoV-2 is only partly under control. So there is still a need for the development of new treatments to combat this and other coronaviruses that may emerge in future.
Scientists at the Institut Pasteur have successfully synthesized two novel molecules that are active against several variants of the virus responsible for COVID-19. The discovery could inspire new families of antiviral drugs against future emerging viral diseases.